within Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX04_Erbium169erCitrateColloid;

model Erbium169erCitrateColloid
  extends Pharmacolibrary.Drugs.ATC.V.V10AX04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Erbium169erCitrateColloid</td></tr><tr><td>ATC code:</td><td>V10AX04</td></tr><td>route:</td><td>intraarticular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Erbium-169 citrate colloid is a radiopharmaceutical used predominantly for the treatment of chronic synovitis by radiosynovectomy, especially in small joints affected by rheumatoid arthritis. It delivers localized beta radiation after intra-articular injection. Its use is limited to specific therapeutic procedures and it does not have broad regulatory approval for routine use.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic studies available; estimates based on related radiocolloid agents administered intra-articularly for synovectomy.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Erbium169erCitrateColloid;
